NCT07736079Not yet recruiting
Evaluation of Serum Preptin Levels in Patients With Polycystic Ovary Syndrome
Evaluation of Serum Preptin Levels and Their Relationship With Insulin Resistance in Patients With Polycystic Ovary Syndrome
Source: ClinicalTrials.gov · Last updated 30 Jul 2026
Brief summary (registry, in English)
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women of reproductive age and is strongly associated with insulin resistance and metabolic dysfunction. Preptin is a pancreatic peptide co-secreted with insulin and has been implicated in glucose metabolism and insulin resistance. However, limited data exist regarding serum preptin levels in patients with PCOS. The aim of this study is to evaluate serum preptin levels in women diagnosed with PCOS and to investigate the relationship between preptin levels and insulin resistance parameters.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 16 Jul 2026
- Start date
- Jul 2026
- Primary completion date
- Sept 2026
- Lead sponsor
- GÜLDEN ANATACA
- NCT number
- NCT07736079
What you commit to
- Study type: Observational
- Planned participants: 60
- From Jul 2026 to the primary completion date, Sept 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- PCOS treatment within the previous 6 months
Other illness
- Active infection
- Rheumatologic or inflammatory disease
- Hypertension
- Diabetes mellitus
- Chronic kidney disease
Age
- Age \<18 years or \>45 years
Other
- Pregnancy or breastfeeding
- Refusal to participate
Who the study is looking for
- Female participants aged 18-45 years
- Diagnosis of PCOS according to Rotterdam criteria
- BMI \<30 kg/m²
- No PCOS treatment during the previous 6 months
- Not pregnant or breastfeeding
- No active infection
- No rheumatologic or inflammatory disease
- No chronic systemic disease
- Written informed consent
Age in the registry: 18 years to 45 years · Sex: Female · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.